Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. (Q53147980)
Jump to navigation
Jump to search
scientific article published on 7 March 2016
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. |
scientific article published on 7 March 2016 |
Statements
Timosaponin A-III reverses multi-drug resistance in human chronic myelogenous leukemia K562/ADM cells via downregulation of MDR1 and MRP1 expression by inhibiting PI3K/Akt signaling pathway. (English)
1 reference
Jie-Ru Chen
1 reference
Xiu-Hong Jia
1 reference
Hong Wang
1 reference
Ying-Jie Yi
1 reference
Jian-Yong Wang
1 reference
You-Jie Li
1 reference
7 March 2016
1 reference
48
1 reference
5
1 reference
2063-2070
1 reference
1 reference
1 reference
Identifiers
1 reference